Eli Lilly will be heading to court to defend itself against allegations that its antidepressant Cymbalta is causing withdrawal symptoms more commonly than the company reported.
Eli Lilly will be heading to court to defend itself against allegations that its antidepressant Cymbalta is causing withdrawal symptoms more commonly than the company reported.
Share this Article
Recommended